SStifel OOracle · ORCL

Stifel Keeps Buy Rating on Oracle

Sep 21, 2026· Analyst: Brad Reback· 1 min read· Reproduced verbatim
Rating
Buy
Price target
Previous
Implied upside

Stifel analyst Brad Reback reiterated a Buy rating on Oracle (NYSE: ORCL).

“While late last week Oracle Cloud Infrastructure VP Mahesh Thiagarajan indicated that construction at Project Jupiter in New Mexico is 26% complete, up 17 percentage points from Oracle’s July update, he also highlighted several hurdles, as the fuel-cell microgrid site was only 10% complete and that there were hold-ups related to various air/water-quality permits and authorization for its gas pipeline.

That said, we note that later in the week the New Mexico Supreme Court unanimously denied a petition from New Energy Economy that requested a cancellation of the air quality permit hearing, and also unanimously denied the Center for Biological Diversity’s challenge to the state’s emergency authorization that granted the site access to a water well in Santa Teresa, ultimately clearing two legal roadblocks to Project Jupiter.

With these hold-ups out of the way, the NMED air quality permit hearing can resume, and developers can restart pumping from the well after more than a three-week pause.

Despite this step in the right direction, we note that no examiner or date has been set for the air-quality hearing.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.